Drug Type Small molecule drug |
Synonyms Glibenclamide/metformin, Glucovance, Glyburide/metformin + [48] |
Target |
Mechanism PRKAB1 activators(Protein kinase AMP-activated non-catalytic subunit beta 1 activators), SUR1 inhibitors(Sulfonylurea receptor 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (31 Jul 2000), |
Regulation- |
Molecular FormulaC27H40Cl2N8O5S |
InChIKeyHCEQQASHRRPQFE-UHFFFAOYSA-N |
CAS Registry338752-31-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus, Type 2 | CN | 01 Jan 2001 |
Phase 1 | - | 60 | (Glyburide Metformin) | mwryyutkyu(tdqdawwpan) = hjrajyoajo tkjrsjrwgm (rlvyhzblxh, pbdssyzyee - kehzfnzbbp) View more | - | 04 Aug 2009 | |
(Glucovance®) | mwryyutkyu(tdqdawwpan) = jpyadrhxtu tkjrsjrwgm (rlvyhzblxh, ymngucpozc - gttynqwrhk) View more | ||||||
Phase 1 | - | 60 | (Glyburide Metformin) | nyhqvjfbdq(yinlzpmskr) = fepcdiqxaf qctwgysxrr (vrgzphvswq, puhsibrudj - ugnevdycfk) View more | - | 04 Aug 2009 | |
(Glucovance®) | nyhqvjfbdq(yinlzpmskr) = sxzyepdrmy qctwgysxrr (vrgzphvswq, zfryxmhbsq - gzpuaaghut) View more |